Ln Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-11-2024
- Paid Up Capital ₹ 0.10 M
as on 04-11-2024
- Company Age 4 Year, 26 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 32.72%
(FY 2023)
- Ebitda -141.26%
(FY 2023)
- Net Worth -66.95%
(FY 2023)
- Total Assets -99.75%
(FY 2023)
About Ln Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manjunath Govindaiah, Gangadharaiah Harsha, and Govindaiah Murthy serve as directors at the Company.
- CIN/LLPIN
U24230KA2020PTC141490
- Company No.
141490
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ln Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manjunath Govindaiah  | Director | 26-Nov-2020 | Current |
| Gangadharaiah Harsha | Director | 26-Nov-2020 | Current |
| Govindaiah Murthy | Director | 26-Nov-2020 | Current |
Financial Performance of Ln Life Sciences.
Ln Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 32.72% increase in profit. The company's net worth observed a substantial decline by a decrease of 66.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ln Life Sciences?
In 2023, Ln Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Banashankari Industries Private LimitedActive 16 years 1 monthManjunath Govindaiah and Govindaiah Murthy are mutual person
Banashankari Chemicals Private LimitedActive 16 years 1 monthManjunath Govindaiah, Gangadharaiah Harsha and 1 more are mutual person
Roots And Shoots Retail LlpActive 4 years 11 monthsManjunath Govindaiah and Govindaiah Murthy are mutual person
- Ln Breweries Private LimitedActive 4 years 17 days
Manjunath Govindaiah, Gangadharaiah Harsha and 1 more are mutual person
- Bsk Solvents & Chemicals Private LimitedActive 9 years 7 months
Manjunath Govindaiah, Gangadharaiah Harsha and 1 more are mutual person
- Ln Solvents Private LimitedActive 3 years 7 months
Manjunath Govindaiah, Gangadharaiah Harsha and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ln Life Sciences?
Ln Life Sciences has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ln Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ln Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
